title: Protective effects of selenium on cadmium toxicity in rats: role of altered toxicokinetics and metallothionein.
abstract: Selenium prevents the toxicity of the carcinogenic metal cadmium through undefined mechanisms. In this study, we determined the effects of selenium on cadmium toxicokinetics and on the ability of cadmium to induce metallothionein, a metal-binding protein that is thought to confer tolerance to cadmium toxicity. To assess the acute protective effects of selenium, male Wistar (WF/NCr) rats were given selenium (as SeO2; 10 mumol/kg, sc) at -24, 0, and +24 h relative to cadmium (as CdCl2; 45 mumol/kg, sc). Over a 14-d period this dose of cadmium killed 6 out of 10 rats, while 100% of the cadmium-treated rats given concurrent selenium treatments survived. The acute increases in testicular weight that were seen with cadmium, indicative of edematous damage, were also prevented by concurrent selenium treatments. Further studies assessed the distribution and excretion of cadmium and its ability to induce metallothionein in rats given 40 mumol Cd/kg, sc, at time 0 and selenium (10 mumol/kg, sc) at -24 and 0 h. Selenium treatments enhanced cadmium accumulation at 24 h in the liver (23%), testes (145%), and epididymis (35%) but reduced renal accumulation by more than half. Urine samples, collected at 0-3, 3-6, and 6-24 h following cadmium administration, indicated a markedly reduced excretion of cadmium in selenium treated rats during all time periods. The synthesis of metallothionein was stimulated to a much lesser extent by cadmium in selenium-treated rat kidney (41% decrease) but was unaffected in liver. The levels of cadmium-binding proteins within the testes were markedly reduced by cadmium treatment, an effect unmodified by selenium treatments. These results suggest selenium prevents acute cadmium toxicity through a mechanism that does not involve induction of metallothionein and in spite of a markedly enhanced retention of cadmium.
authors.affiliation: Inorganic Carcinogenesis Section, National Cancer Institute-FCRDC, MD 21702.
authors.forename: Z Z
authors.initials: ZZ
authors.lastname: Wahba
authors.forename: T P
authors.initials: TP
authors.lastname: Coogan
authors.forename: S W
authors.initials: SW
authors.lastname: Rhodes
authors.forename: M P
authors.initials: MP
authors.lastname: Waalkes
mesh_terms: D000818:Animals; D002104:Cadmium / Q000493:pharmacokinetics* / Q000652:urine; D002105:Cadmium Poisoning / Q000378:metabolism / Q000401:mortality / Q000517:prevention & control*; D007279:Injections, Subcutaneous; D008297:Male; D008668:Metallothionein / Q000096:biosynthesis* / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D012643:Selenium / Q000627:therapeutic use*; D014018:Tissue Distribution
chemical_list: C004203:cadmium-binding protein; D002104:Cadmium; D008668:Metallothionein; D012643:Selenium